PEG-MGF: research, legal status and who sells it
This page is information, not medical advice. PEG-MGF is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- Pegylated mechano growth factor, Mechano growth factor, pegylated
- Category
- Pegylated form of mechano growth factor (MGF), an isoform of insulin-like growth factor 1
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $10.00/mg to $25.00/mg, median $19.98/mg across 14 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | Not FDA-approved; the compounding nomination for PEG-MGF was withdrawn after FDA said it may pose a significant risk of immune reactions for some routes of administration and found no human exposure data, and FDA plans to consult its advisory committee on it before the end of February 2027 [1][2][3]. |
| United Kingdom | No UK-licensed medicine containing PEG-MGF appears in the MHRA products database [4]. |
| European Union | No medicine containing PEG-MGF is authorized in the EU, according to EMA's central and Article 57 product data [5][6]. |
| Canada | No product containing PEG-MGF appears in Health Canada's Drug Product Database [7]. |
| Australia | PEG-MGF is not named in Australia's Poisons Standard (October 2026), which lists insulin-like growth factors in Schedule 4 with Appendix D possession controls [8]. |
| Sport (WADA) | Mechano growth factors (MGFs) are named under S2 of the 2026 Prohibited List and banned at all times [9]. |
We haven't published a full overview of PEG-MGF yet. The legal status table and live prices on this page are current.
PEG-MGF compared
PEG-MGF prices: cheapest listings
The five lowest $/mg listings out of 16. See all PEG-MGF prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Alpha Peps | 78 | 5 mg | $50 | $10.00/mg | View | ||
| Amino Asylum (aminoasylumofficial.com) Red flags | 47 | 2 mg | $30 | $14.99/mg | Red flags | ||
| Biotech Peptides | 47 | 5 mg | $79 | $15.80/mg | View | ||
| Peak Lab Peptides | 73 | 2 mg | $33 | $16.50/mg | View | ||
| AIO Peptides | 52 | 2 mg | $34 | $16.88/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of 22 April 2026). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- Meeting of the Pharmacy Compounding Advisory Committee (to be held before the end of February 2027). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "peg-mgf". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- The role of mechano growth factor in chondrocytes and cartilage defects: a concise review. Acta Biochimica et Biophysica Sinica (2023). Accessed Oct 15, 2026
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Frontiers in Endocrinology (2026). Accessed Oct 15, 2026